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Abstract: Persons experiencing homelessness have a high prevalence of severe mental health
problems, alcohol dependence, substance misuse and infectious hepatitis C, and face up to twelve
times higher mortality rates compared to the general population. They also face barriers to accessing
healthcare. However, clinical pharmacy services are currently not available to homeless populations in
England. The aim of this study was to conduct public involvement sessions with persons experiencing
homelessness with a view to inform the design of patient-centred clinical pharmacy healthcare services.
Qualitative methodology was used, using a focus group with homeless persons from emergency
shelters and one to one engagement with those sleeping rough, using a topic guide. A total of nine
homeless persons took part—seven males and two females. The participants of the sessions said that
patient-centred clinical pharmacy services delivered for homeless persons would address many of their
unmet needs around access to medicines, their understanding of prescribed medicines and holistic
management of their health. The service would be able to make a positive impact on their health
outcomes by screening for health conditions, facilitating better integration across services, referral
and liaison with other services, and minimising misuse of prescribed medicines. The findings of this
study will be used to inform the development, implementation and evaluation of a patient-centred
clinical pharmacy service tailored to meet the specific needs of the homeless population.
Keywords: homelessness; clinical pharmacy services; health inequality; public involvement
and engagement
1. Background
There are an estimated 250,000 people known to be homeless in England alone [1,2] including
4000 people sleeping rough on any given night [3]. The number of rough sleepers in urban areas such
as London has doubled in the last 6 years [3].
People experiencing homelessness face up to twelve times higher mortality rates compared to the
general population [4]. They die at an average age of 43 to 45 years [5]. A recent study conducted with
over 900 homeless people in England showed a high prevalence of severe mental health problems,
alcohol dependence, substance misuse and infectious hepatitis C [6]. A study in Scotland showed that
the extent of multi-morbidity in homeless population, with a mean age of 40 years, was comparable to
persons over 85 years in the general population [7].
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Despite their poor health, people experiencing homelessness use health services differently to the
general population [8]. Barriers include difficulty registering at a general practice due to lack of proof
of address, inadequate signposting from healthcare staff, and perceived stigma and discrimination
in healthcare settings [8,9]. They often lack the knowledge, and the physical and mental capacity to
navigate services [8].
Homeless populations also experience reduced prescribing of medicines, and face barriers to
accessing and managing their medicines. Cardiovascular diseases, mental health and substance misuse
issues are often undiagnosed and under-treated [9–11]. Therefore, they have an increased rate of
use of unscheduled care, with high resource and cost implications to healthcare services. There is a
need for innovative service models to be tested and implemented, given the established link between
homelessness and poor health.
To facilitate engagement, fulfil the complex healthcare needs of homeless persons, and minimise
access barriers, specialist primary healthcare centres for persons experiencing homelessness have been
established across the UK. Such specialist centres aim to offer diverse services under one roof [12].
In Scotland, people who are homeless in Glasgow and Edinburgh have access to clinical pharmacists in
the specialised homelessness health services and on outreach. However, clinical pharmacy services are
currently not available to homeless populations in England, including those in the specialist settings.
This is despite recent UK policies advising that the pharmacy workforce increase their role in reducing
health inequality including amongst vulnerable groups [13,14]. Approximately 7500 (of the total
56,000 pharmacists in Great Britain) have qualified as an independent prescriber, allowing them to
diagnose common medical conditions within their competency, prescribe medicines and make referrals.
Recent work described the perceptions of people who are homeless of pharmacists delivering
clinical services in Glasgow [15]. Findings included the service acting as a bridge into mainstream
health services, and the pharmacists were reported to have improved patient health, while increasing
patient perceptions of the importance of health [15].
This study aimed to conduct public involvement sessions using qualitative methodology to inform
a proposal to develop a novel, patient-centred clinical pharmacy service for homeless persons in an
English specialist homelessness health service and outreach setting, including temporary shelters
and streets.
2. Method
A public involvement session using qualitative methodology was used. Patient and public
involvement relates to input from members of public or patients in the actual design, undertaking,
analysis or dissemination of findings, as opposed to their participation as research subjects. The
National Institute of Health Research (NIHR) INVOLVE defines public involvement in research as
activities being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them [16].
Public involvement sessions are a pre-requisite as part of the submission of a research proposal, for
funders including NIHR.
This study was approved and funded by the National Institute of Health Research (NIHR) Research
Design Service at University of Birmingham as a public involvement event, hence ethical approval
was not required. However, informed written consent was obtained from focus group participants to
record the conversation and use anonymised quotes for publication. Conversation was not recorded
during public engagement with persons sleeping rough and only verbal consent was obtained.
A focus group and one to one engagement with persons currently experiencing homelessness
were conducted. A focus group lasting approximately one hour was led by VP and PJ and was held at
an emergency accommodation for persons experiencing homelessness. A total of ten registrants of a
specialist homeless healthcare centre who had four or more prescribed medications were identified
and invited by clinical staff at the specialist centre and were sent a letter of invitation to participate
in the focus group. In addition, participants with multiple long-term health problems (as identified
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by shelter wardens—a list of conditions was not pre-specified) were also invited from the temporary
shelter where the focus group took place.
The focus group was conducted in a communal area within the temporary shelter for people
experiencing homelessness. Participants were provided with an information sheet in advance through
postage or in person when invited to the event. The focus group was recorded and transcribed verbatim
and analysed using thematic coding.
Public engagement was also conducted with people sleeping rough. The researcher was
accompanied by a charity worker and a substance misuse nurse for public involvement sessions in
the street.
All participants were provided with a shopping voucher of £10 each, lunch, and reimbursed for
any bus travel costs incurred.
Both focus group and semi-structured interviews were conducted using a topic guide (Box 1)
developed amongst the research team, based on the objective of the study and researchers’ previous
experience around healthcare of homeless populations [8,9,17]. Data were analysed using thematic
coding of the focus group transcript and notes taken during one to one engagement. Data saturation
was not intended and detailed qualitative research methodology grounding was not considered in
analysis, due to the adoption of public involvement methodology.
Box 1. Study topic guide.
• Why do you come to the specialist healthcare centre/use the services of the outreach team?
• Who would you expect to see/what types of staff—clinical/social care/support services?
• Have you faced problems in accessing health services before?
• Have you come across a pharmacist before?
• How do you think a pharmacist coming to you in the street as part of the outreach team or at the specialist
healthcare centre can help you?
• Do you think having a pharmacist at the specialist healthcare centre /outreach team is a good idea?
• How do you feel about pharmacist doing health MOT for persons experiencing homelessness? E.g., screen
for chronic health conditions each such as cardiovascular, respiratory, mental illness, anxiety and depression,
alcohol and substance misuse, diet, podiatry, teeth
- Medication review, adherence, starting/stopping medicines, monitoring
- Signposting to other services [Prompt: how should they be doing it, where should they be doing it?]
• What issues do you face in getting and keeping the medicines you require?
• Do you often get enough time to discuss your medicines with your doctors, nurses?
• How do you feel about receiving support about your medicines from the pharmacist at the Health
Exchange/outreach team? [prompt: optimising medicines, adding or reducing the number of medicines
based on the checks, advice on storing medicines, getting your medicines, pharmacist liaising with the
community pharmacist for you to get medicines on time, etc.]
• What differences (outcomes) do you think a pharmacist can make to a person experiencing homelessness?
3. Results
Altogether, nine participants took part in the public involvement events. This included seven
(six males, one female) participants in the focus group, and two persons sleeping rough, including
one female. The focus group and street engagement lasted approximately 1 hour and 20 minutes,
respectively. Key themes from the discussion are presented below, with illustrative quotes presented
from the focus group where available. Quotes are not available from individual engagement sessions
with persons sleeping rough, as conversations were not recorded and consent to publish their direct
quote was not sought, due to practicalities around health literacy and the consent process.
3.1. Acquaintance with Pharmacy Services
Participants described using community pharmacy services for collecting their prescribed
medicines. However, most of them described having a very low or no interaction with a community
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pharmacist when collecting their prescription. This lack of interaction was related to the busy
environment of a community pharmacy. Minimal experience of pharmacist service in general practice
was mentioned.
‘There wasn’t the opportunity to talk to the pharmacist . . . they don’t say, they just say a ten
minute wait, that’s the only conversation you’re going to have.’ M 49
‘My experience is, it’s not good. You’re in a queue . . . And also, I put a prescription in on a
Saturday, couldn’t get it till Monday so, I’d missed a couple of tablets anyway . . . ’ M 56
3.2. Perceived Feasibility and Benefits of a Clinical Pharmacy Service
Participants described their experience of visiting their doctor, nurse practitioners, substance
misuse nurse and charity workers at the specialist healthcare centre, but not a pharmacist. Participants
involved in the discussion mentioned that a clinical pharmacy service based at the specialist homeless
healthcare would address many of the barriers homeless persons were facing around access to medicines
and healthcare in general.
a) Facilitating Access to Medicines
Participants described that they face a physical inability to visit a pharmacy, due to their
multi-morbidities and illnesses and, hence, would often miss the collection of prescriptions. They
would value clinical pharmacists’ help in facilitating timely collection of medicine at the specialist
healthcare centre, as this was close to their temporary shelters.
‘I’ve got to walk on my heel sometimes, very painful, and if there was a pharmacist down
there that’d save me a trip.’ M 50a
‘Yeah, I’ve missed medication cause I, I couldn’t get, cause I suffer with arthritis so, certain
days I, it’s a no go even walking, I can’t walk . . . ’ F 55
b) Understanding Prescribed Treatments
Participants described that they often lacked understanding about their prescribed medicines.
They would value somebody with expertise in medicine to ‘listen’ and develop a ‘rapport’ with
them. One person described that often patients did not understand what was prescribed to them and
there was not enough opportunity to query prescribing decisions by the doctors, due to lack of time.
A clinical pharmacist based at the specialist primary healthcare centre would facilitate discussion of
medicine-related issues. This would aid patient understanding of reasons for prescribing medication
and its potential side-effects or interactions, and support better management of health conditions
‘I’ve recently started a new medication cause I was already diagnosed, dual diagnosis, when
I was in prison I had an addition diagnosis, I started a new medication but, I’ve not had a
chance to speak to anybody about the medication or potential side effects, whatever, whereas
if there was a pharmacist there at the time, that would’ve helped a lot . . . and maybe if the
doctor’s being awkward with you or you think that the doctors being unfair, if you’ve got a
pharmacist to talk to, they can either back up what the doctor says or back up what you’re
saying and then maybe they can go to the doctor. That would be good.’ M 50b
References were also made to the side effects of the medicines and potential role of pharmacists in
preventing and managing the side effects.
‘When they put me on the medication in jail that was an anti-psychotic as well. So, I mean,
and if you’re not the right person for that medication it can have really adverse effects.
Luckily, I was the right person for it but . . . ’ M 50b
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c) Better Integration across Services
One participant also described a lack of liaison between primary and secondary care and prison
services, which often lacked an effective transition of care, particularly with regards to prescribed
medicines. A clinical pharmacist would be able to bridge such barriers.
‘I went to hospital once, cause I had an operation, it was stent, stent, yeah, got some but my
doctor didn’t know about it until I look a letter to my doctor. He hadn’t had a copy so, he
didn’t know what to prescribe me, he wasn’t even aware of the operation . . . ‘. ‘I started
heroin in jail cause they stopped my co-codamol. So, I pay for this, and my codeine.’ M 50a
d) Referral and Liaison with Other Services
Participants also mentioned that pharmacists would be ideal in facilitating their access and
engagement with mental health services, as they had an expert understanding of medicines for mental
health conditions and the negative impact of a disjointed approach towards the health and well-being
of a patient. One of the persons sleeping rough mentioned that many homeless people were often
reluctant to be admitted to hospitals, as many hospitals do not offer substance misuse services to
inpatients. Clinical pharmacists would hence be effective in their referral process, by identifying and
liaising with the ‘right’ hospitals and making sure that patients do not miss their prescribed treatments
while in hospital.
e) Minimising Misuse of Prescribed Medicines
Participants described that misuse of prescribed medicines was often common amongst persons
experiencing homelessness, as many of them had substance misuse problems. A pharmacist, as an
expert in medicines who is based at the specialist centre, would be able to help address substance
misuse by diagnoses, advice and referral to substance misuse services
‘ . . . it helps them see if people are abusing their meds, know what I mean, they might see
them taking too many straight away or selling on, stuff like that.’ M 50b
f) Screening, Diagnosis of Health Conditions and Prescribing of Medicines
Participants mentioned that they would trust pharmacists with screening for diseases, diagnostic
skills and prescribing medicine and provided examples of their previous experience of pharmacists’
diagnostic skills.
‘Sometimes pharmacists are better at diagnosis than doctors, in my eyes.’ M (age not known)
‘I have one doctor saying I’ve got osteoarthritis, but my pharmacist said no, no, it’s rheumatoid,
it is the other one, yeah . . . and the doctor said, no, it’s rheumatoid arthritis, you know, cause
I worked in water, I was a plasterer by trade, so work in water over the years, hands shrank.’
M 50a
One rough sleeper mentioned that his blood pressure or any form of cardiovascular risk assessment
was not done ‘for years’ as nobody had ‘come to’ him and that they were not registered with any
general practice. One of the participants of the focus groups currently living in an emergency shelter
also said that persons sleeping rough would most benefit from outreach visits.
‘Most people sleeping rough have got multiple problems going on but just don’t (have access
to services). They seem to be the sort of people that don’t go to doctor’s appointments, don’t
go and see doctors, don’t go and get it taken care of. Cause they’re living their day to day
routine on the streets, whatever it is they have to do . . . they’re developing multiple physical
or mental problems, but they (also) never search for any help so, a pharmacist going out
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to them, they’d be getting the care and attention that they should be getting but, they’re
choosing not to for whatever reason. They probably get, they’d probably benefit more from
it than anyone.’ M 50b
3.3. Prospect of Outreach Visits by Pharmacists
Participants suggested that pharmacists could visit persons experiencing homeless in temporary
shelters, emergency accommodation and streets during outreach. They mentioned that some patients
may be unable to walk to the specialist primary healthcare centre or make appointments and hence
outreach would ensure continuity of care.
‘They (persons experiencing homelessness) don’t go to a doctor . . . so, if you went out to
them . . . they would probably open up to you.’ F 55
3.4. Peer Support and Social Influences in Engaging with Services
Participants mentioned that social influences were key in encouraging people sleeping rough to
engage with outreach services by pharmacists.
‘And when one person hears from another that they, they sent the wellbeing bus or whatever
and it helps them, and they move on or they got better. Word of mouth alone is going to
build trust amongst these people.’ M 50b
One participant suggested that a peer support network would facilitate engagement with the
outreach services.
‘Suggesting recruiting people like us, who are already on the street, some of us, going to
know certain people, and I’m just getting nowhere, here mate, I’ll signpost you to them. I
mean what is it really, are you going to go out yourself or you’re going . . . ’ M 50a
3.5. Addressing Challenges in Following up Homeless Persons
Participants were requested to suggest ways to address the challenges to follow up people
experiencing homelessness during their care. They mentioned that building trust and rapport means
participants were more likely to agree a mutual meeting point either at the specialist homeless healthcare
centre, at the temporary shelter or at a natural venue.
4. Discussion
Public involvement sessions were held with persons experiencing homelessness with a view
to inform the development, implementation and evaluation of patient-centred clinical pharmacy
interventions for homeless persons. The participants of the session described that a clinical pharmacy
service tailored to this specialist population was a feasible idea that could deliver benefits to the
patients. However, the low sample size of this study means that study results are not generalizable
and there is a need to develop, implement and evaluate the intervention to identify the evidence base.
This would address the unmet needs of homeless persons around access to medicine, support their
understanding of prescribed medicines and improve health outcomes. Participants suggested that
the best way to deliver primary healthcare to people sleeping rough was to promote engagement by
building trust, and for the health service to ‘reach out to them’ when needed.
Pharmacy 2019, 7, 153 7 of 10
Participants of the sessions trusted pharmacists to screen for health and long-term conditions
and provided examples to back up their assertions. A novel, pharmacist-led health outreach service
for homeless people has been delivered and evaluated in Glasgow [18]. In this study, pharmacists
provided pop-up, drop-in (no appointment needed) health clinics at various homeless support venues.
Medications were prescribed by pharmacists in 62% of all patients, of which over two thirds were
new medications. New clinical issues were identified in 69% of patients. More importantly, this
exploratory study showed an improvement in patient engagement with the service, with 85% of patients
subsequently attending either a follow-up with the pharmacist or with other referred services. It is
proposed that the service for England should similarly be able to introduce screening for cardiovascular
health, blood borne viruses, and sexual health.
There is very little published literature on clinical pharmacy services for homeless persons from
outside the UK. A study conducted in the US [19], which included pharmacists and pharmacy students
offering free primary healthcare services to 100 homeless persons, showed that the pharmacy team
were able to diagnose new health conditions including diabetes, hypertension, and hyperlipidaemia,
and identify medication-related problems, which mostly included under-prescribing or ineffective
drug prescribing. The pharmacy team also facilitated access to free medicines in a private healthcare
system. Data collected six months prior to and after the implementation of the services showed an
improvement in clinical outcomes for patients enrolled in the clinical pharmacy programme. Statistical
comparisons were not available, due to limited sample size. Another observational study in the US also
demonstrated pharmacists’ contribution to reducing medication-related issues in homeless persons,
which mostly related to under-prescribing, inappropriate medication prescribing and suboptimal
doses [20].
A systematic review of the international literature, which did not include the aforementioned
studies, demonstrated a dearth of, and, hence, a need to generate, evidence for the management
of communicable and non-communicable diseases in persons experiencing homelessness [21]. The
review showed that, of the 11 included studies, none of the previous studies included clinical
pharmacy interventions.
Some of the outcomes of the public involvement sessions corroborate with our recent qualitative
study that aimed to investigate the barriers for people experiencing homelessness to access health
services [8]. They experienced difficulty registering at a general practice due to lack of proof of address,
inadequate signposting from healthcare staff, and perceived stigma and discrimination in healthcare
settings. They often lacked the knowledge, and the physical and mental capacity to navigate services,
which were often deemed to be fragmented. These views were also shared by participants in the public
involvement sessions who were currently homeless. Wider policy and practice changes are needed to
promote service integration [22].
Participants in these public involvement sessions said that they would trust pharmacists to
prescribe medicines to them. Cardiovascular diseases, mental health and substance misuse issues
are often undiagnosed and under-treated [6,10,11], and pharmacists have the potential to address
these issues.
4.1. Strengths and Limitations
To our knowledge, this is the first report of a public involvement session that included persons
experiencing homelessness to discuss their suggestions on the value and nature of clinical pharmacy
services. Engagement can be difficult, as persons experiencing homelessness lack stable accommodation.
Meeting participants in emergency accommodation, or on the street with healthcare workers that they
are already familiar with, provides a safe environment in which to explore their views.
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Given that the study was focused on an under-researched area, an exploratory approach using
qualitative methodology was considered most appropriate, as these are suited over survey designs
which mainly serve ‘confirmatory’ purposes. Homeless persons are often a hard to reach population
and it is a norm for a small sample size to be utilised in research involving homeless persons. We did
not subject a recruitment strategy for data saturation. Therefore, the findings of this study are not
meant to be generalizable to the wider homeless population in the UK.
During the discussion, the researchers introduced themselves as being affiliated to the pharmacy
discipline and, therefore, there may have been some degree of social desirability bias [23] in participants’
responses to the questions. However, to minimise such bias, the researchers assured participants
that there were no right or wrong answers to any questions prior to the start of the interviews, with
researchers interested in a range of views on the topic of discussion.
4.2. Future Plans
Suggestions for clinical pharmacy interventions are being incorporated into intervention design
and development. Funding will be sought from relevant agencies in the development, implementation
and evaluation of services. Educational interventions to support pharmacists in other settings, such as
community pharmacy, is also required to promote joined-up working [24].
5. Conclusions
Public involvement sessions were conducted to inform the feasibility, design and development
of clinical pharmacy intervention for persons experiencing homelessness. The outcomes provide
recommendations that persons experiencing homelessness perceive that a clinical pharmacy service
would bring multiple benefits around access to and use of medicines, and facilitate access and
integration of services for person-centred care. The findings will be used to develop a feasibility and
pilot intervention that aims to explore the benefits of clinical pharmacy service in primary care to the
health of persons experiencing homelessness.
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